RH

Russell Howard

Immutep Limited | Non-Executive Chairman, Non-Executive Director
Dr Howard is an executive manager, and entrepreneur. He is an inventor of 9 patents and has over 140 scientific publications. He held positions at several research laboratories, including the National Institutes of Health in the USA where he gained tenure. In industry, Dr Howard worked at Schering-Ploughs DNAX Research Institute in Palo Alto, CA, was the President and Scientific Director of Affymax, Inc. and co-founder and CEO of Maxygen, Inc. After its spin-out from GlaxoWellcome as Maxygens CEO. After leaving Maxygen in 2008, he started the Cleantech company Oakbio Inc (dba NovoNutrients) and remains involved in several innovative companies in the USA and Australia. He is currently Non-Executive Chairman of NeuClone Pty Ltd.He is a member of risk committee.

Company and Roles

Company
Title
Tenure
Since
IMM
IMM
Immutep Limited
  • Non-Executive Chairman
  • Non-Executive Director
13yrs, 5mthMay 2013

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMM
IMM
Immutep Limited
30/06/26N/A1,717,977N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMM
IMM
Immutep Limited
04/12/25
Exercise
300,000$0.255$76,500Conversion of securities
IMM
IMM
Immutep Limited
04/12/25
Issued
300,000$0.255$76,500Conversion of securities
IMM
IMM
Immutep Limited
02/12/25
Issued
1,573,646$0.280$440,620Issue of securities
IMM
IMM
Immutep Limited
06/12/24
Issued
304,770$0.330$100,574Conversion of securities
IMM
IMM
Immutep Limited
06/12/24
Exercise
304,770$0.330$100,574Conversion of securities